Divis LaboratoriesNSE: DIVISLABBSE: 532488Healthcare · PharmaceuticalsDivis Laboratories Technical Analysis
Divis Laboratories is trading at ₹8,056.00. That places it 105% up its 52-week range of ₹5,636.50 to ₹7,938.00. Pivot levels, Central Pivot Range and live indicator readings are below. These describe price behaviour that has already happened and are not investment advice.
- Last traded price
- ₹8,056.00
- Technical bias
- Strong bullish
- 52-week position
- 105%
- 52-week high
- ₹7,938.00
- 52-week low
- ₹5,636.50
- Session range
- ₹7,870.50 – ₹8,090.00
- Pivot
- ₹8,005.50
- CPR width
- ₹50.50
Bias describes where Divis Laboratories is trading within its own 52-week range. It is a description of past price behaviour — not a forecast, a target or a recommendation.
Divis Laboratories pivot levels and Central Pivot Range
Derived from the session's high, low and close. Pivot levels are reference points traders watch, not predictions of where price will go.
| Level | Price |
|---|---|
| R3 — Resistance 3 | ₹8,360.00 |
| R2 — Resistance 2 | ₹8,225.00 |
| R1 — Resistance 1 | ₹8,140.50 |
| Pivot | ₹8,005.50 |
| S1 — Support 1 | ₹7,921.00 |
| S2 — Support 2 | ₹7,786.00 |
| S3 — Support 3 | ₹7,701.50 |
| Central Pivot Range | Price |
|---|---|
| Top Central (TC) | ₹8,030.75 |
| Pivot | ₹8,005.50 |
| Bottom Central (BC) | ₹7,980.25 |
Divis Laboratories indicators
RSI, MACD and moving-average signals, refreshed from the live tape during market hours.
How this is calculated
Indicators are computed from exchange price and volume data on the stated timeframe. Pivot and CPR levels derive from the previous session’s high, low and close. Technical readings describe price behaviour that has already happened; they are not forecasts and not investment advice.
Index membership reflects the Nifty 100 as published by NSE Indices, effective 2026-03-30.
Divis Laboratories: frequently asked questions
Where is Divis Laboratories trading in its 52-week range?
Divis Laboratories last traded at ₹8,056.00, which is 105% of the way up its 52-week range of ₹5,636.50 to ₹7,938.00.
What is Divis Laboratories's 52-week high and low?
Divis Laboratories's 52-week high is ₹7,938.00 and its 52-week low is ₹5,636.50.
What are the support and resistance levels for Divis Laboratories?
The pivot table on this page lists classic support (S1-S3) and resistance (R1-R3) levels calculated from the session's high, low and close. These are widely-watched reference levels, not forecasts.
What is the Central Pivot Range (CPR)?
The Central Pivot Range is the band between the Top Central and Bottom Central levels around the daily pivot. A narrow CPR relative to the day’s range is often read as a trending setup and a wide one as rangebound, but it describes prior price action rather than predicting the next move.
Is Divis Laboratories a buy?
This page does not make buy, sell or hold recommendations. It reports indicator readings and price levels derived from exchange data. StockeZee is not a SEBI-registered investment adviser — please consult one before acting on any market data.
How often do these technical readings update?
Indicator values refresh from the live tape during market hours. Pivot and CPR levels are derived from the session’s high, low and close, and the timestamp above shows when the page data was generated.
More Divis Laboratories data
Compare technical analysis with peers
Comparing technical analysis across companies is more useful than reading one in isolation — the peer links above open the same view for Divis Laboratories’s closest listed competitors.
The data, ratios and commentary about Divis Laboratories Ltd (DIVISLAB) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.